Therapeutic Area Policy Director

Genentech•Daly City, DC

1d•$184,100 - $341,900•Hybrid

About The Position

The Therapeutic Area Policy team is seeking a strategic, forward-thinking Policy Director to shape the product-level healthcare policy landscape and optimize patient access across a diverse portfolio. Working at the intersection of business and policy strategy for key Genentech therapeutic areas, you will catalyze and collaborate seamlessly across Commercial, Medical, and Government Affairs teams to navigate and influence evolving Medicare, Medicaid, and commercial payer coverage and access policies—ensuring that life-changing innovation successfully reaches the patients who need it most. In this role, your core focus will span: In-Line Excellence: Leading policy and reimbursement strategy for our world-class Oncology portfolio Pipeline Readiness: In partnership with External Affairs, proactively shaping the policy environment for innovative new therapies in emerging areas such as, but not limited to, Alzheimer’s Disease and obesity IRA Strategic Leadership: Spearheading cross-functional business impact assessments and driving strategic readiness in response to key drug pricing policies under the Inflation Reduction Act (IRA)

Requirements

Extensive knowledge of federal and state regulatory processes, including Medicare and Medicaid coverage, coding, and payment policies.
Demonstrated ability to navigate the intersection of public policy and commercial markets, including how commercial healthcare payment and delivery trends impact public payers and vice versa.
Experience in Alzheimer’s Disease, Obesity, and/or Oncology is highly preferred, though not required.
Proven ability to navigate ambiguity and develop creative policy levers that clear complex market barriers, while clearly outlining strategic trade-offs and mitigation plans for senior leadership.
Advanced ability to synthesize complex policy developments and market access insights into clear, actionable narratives.
Proven expertise in tailoring communication styles across diverse stakeholder groups and delivering persuasive, data-driven presentations to senior management.
Ability to lead large cross-functional teams, manage internal stakeholders, and influence at very senior levels.
A track record of building trust and driving alignment across diverse internal teams and external partners.
A Bachelor’s degree
At least 10 years of relevant post-college healthcare policy experience. Examples include government agencies such as HHS, CMS, State Medicaid Agencies, CBO, OMB, GAO, or FDA; Congress; healthcare consulting firms; pharmaceutical, biotechnology, managed care or other healthcare industries; or patient, provider or trade associations.
Ability to travel up to 20% of the time (more if remote or not near SSF or DC offices)

Nice To Haves

Advanced degree in biological sciences, health policy, or related field
Experience working at CMS, directly with HHS on healthcare policy, or as Congressional health policy staff

Responsibilities

Proactively monitor and evaluate the business impact of evolving federal and state policy trends and reimbursement changes across assigned therapeutic areas. Translate complex policy developments and market barriers into actionable policy strategies and clear, high-impact recommendations for internal stakeholders and senior leaders.
Maintain a deep understanding of therapeutic area-specific market dynamics and brand priorities across the lifecycle. Partner with brand leadership to clearly articulate policy risks, opportunities, and trade-offs to inform critical business decision-making.
In close alignment with External Affairs partners, lead strategic engagements with the Centers for Medicare and Medicaid Services (CMS), Center for Medicare and Medicaid Innovation (CMMI), other government agencies, and third-party policy stakeholders to shape policy environments that optimize patient access to Genentech products.
Champion and lead seamless cross-functional collaboration with internal partners (e.g, External Affairs, Access Business Partners, Marketing, Evidence for Access) to align, pull through, and execute therapeutic area policy objectives, including, but not limited to, advancing evidence generation strategies and patient partnerships to amplify policy advocacy.
Steer the cross-functional Inflation Reduction Act (IRA) Work Product Team (WPT); lead enterprise-wide readiness, business impact assessments in partnership with Digital, Data, and Analytics (DDA), and drive the continued strategic integration of IRA drug pricing policy considerations into commercial, pipeline, and product lifecycle decision-making.
Serve as a trusted mentor and coach across the Therapeutic Area Policy (TAP) and wider Policy, Evidence, and Access Strategy (PEAS) teams; actively support the professional development of other team members, foster a culture of continuous learning, and elevate the team's collective strategic capabilities.